<DOC>
	<DOC>NCT02159729</DOC>
	<brief_summary>Long-term follow-up study of subjects who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)</brief_summary>
	<brief_title>Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101</brief_title>
	<detailed_description>No study medication was administered in this study.</detailed_description>
	<criteria>Any subject who successfully completed a Kytherasponsored clinical trial of ATX101 (0603, 0707, 0915) Signed informed consent Willingness to comply with schedule and procedures of the study Subjects who have had or are undergoing treatment that may affect the evaluation of the submental area will be excluded</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>